Through RIP experiments, we validated the direct binding between YTHDC1 and LNCAROD (Figure 1N), and silencing YTHDC1 in ESCC cells significantly reduced LNCAROD level (Figure 1O and P). Here, YTHDC1 is linked to esophageal squamous cell carcinoma.